Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.873
Filter
1.
An. Fac. Cienc. Méd. (Asunción) ; 54(3): 143-150, Dec. 2021.
Article in Spanish | LILACS | ID: biblio-1352977

ABSTRACT

El trasplante renal de órganos provenientes de donantes adultos implantados en una cavidad anatómica estrecha en pacientes pediátricos de bajo peso, ofrece importantes desafíos médicos y quirúrgicos a ser considerados. En esta publicación reportamos el primer caso en el Paraguay de un riñón con dos arterias renales injertado a la aorta y vena cava inferior, dentro de la cavidad abdominal de un paciente pediátrico de 12 kilogramos de peso, evaluando las dificultades médicas, anatómicas y quirúrgicas enfrentadas, así como las opciones de tratamiento instituidas para llevar a cabo este procedimiento de manera exitosa


Kidney transplantation of organs from adult donors implanted into a narrow anatomical cavity in underweight pediatric patients offers significant medical and surgical challenges to be considered. In this publication we report the first case in Paraguay of a kidney with two renal arteries, grafted to the aorta and inferior vena cava within the abdominal cavity, on a 12 kilogram pediatric patient, evaluating the medical, anatomical and surgical conditions faced, as well as the treatment options instituted to successfully carry out this procedure


Subject(s)
Kidney Transplantation , Kidney , Arteries
2.
Aquichan ; 21(3): e2136, sept. 30, 2021.
Article in English, Portuguese | LILACS, BDENF, COLNAL | ID: biblio-1292401

ABSTRACT

Objectives: Mapping nursing care in kidney transplant patients. Materials and method: A scoping review was conducted according to the recommendations of the Joanna Briggs Institute Reviewers' Manual. Data were collected through 13 national and international databases from December 2020 to January 2021, following scientific rigor in the selection of the material. The pre-selection was made by reading the title, abstract and introductory text in advance; the materials included in this stage were read in full to define the content for the study. Results: Fifteen studies were included. Of these, 60% are articles; dissertations, manuals, protocols, guidelines and bulletins totaled 40% of the material studied. 86.6% of the material has a quantitative approach. Regarding the methodological design, 73.3% were descriptive/transversal character studies. Regarding the mapping of nursing care, it was possible to divide them into two categories: nursing care after kidney transplantation (immediate, mediated and late) and nursing care after kidney transplantation in primary health/extra-hospital care. Conclusions: It is concluded that the study allowed mapping nursing care to kidney transplant patients in the immediate, late and primary health care periods.


Objetivos: mapear los cuidados de enfermería en pacientes trasplantados renais. Materiales y método: scoping review conducida conforme las recomendaciones del Joanna Briggs Institute Reviewers' Manual. Se recolectaron los datos por medio de 13 bases de datos nacionales e internacionales de diciembre del 2020 a enero del 2021, siguiendo rigor científico en la selección del material. La preselección se dio mediante lectura previa de título, resumen y texto introductorio; los materiales incluidos en esta etapa se leyeron en la íntegra con el fin de definir el contenido para el estudio. Resultados: se incluyeron 15 estudios. De estos, el 60 % es artículo; tesis, manuales, protocolos, directrices y boletines suman 40 % del material estudiado. El 86,6 % del material presenta enfoque cuantitativo. En cuanto al diseño metodológico, el 73,3 % son estudios de tipo descriptivos/transversales. Con relación al mapeo de los cuidados de enfermería, se logró dividirlos en dos categorías: cuidados de enfermería post trasplante renal (inmediato, mediato y tardío) y cuidados de enfermería post trasplante renal en la atención primaria a la salud/extra hospitalaria. Conclusiones: se concluye que el estudio permitió mapear los cuidados de enfermería al paciente trasplantado renal en los posoperatorios inmediato, mediato, tardío y en la atención primaria a la salud.


Objetivos: mapear os cuidados de enfermagem em pacientes transplantados renais. Materiais e método: scoping review conduzida conforme as recomendações do Joanna Briggs Institute Reviewers' Manual. Os dados foram coletados por meio de 13 bases de dados nacionais e internacionais de dezembro de 2020 a janeiro de 2021, seguindo rigor científico na seleção do material. A pré-seleção se deu mediante a leitura prévia de título, resumo e texto introdutório; os materiais incluídos nessa etapa foram lidos na íntegra a fim de definir o conteúdo para o estudo. Resultados: foram incluídos 15 estudos. Destes, 60 % são artigos; dissertações, manuais, protocolos, diretrizes e boletins somaram 40 % do material estudado. 86,6 % do material apresenta abordagem quantitativa. Quanto ao desenho metodológico, 73,3 % eram estudos de tipo descritivos/transversais. Quanto ao mapeamento dos cuidados de enfermagem, pôde dividi-los em duas categorias: cuidados de enfermagem pós- transplante renal (imediato, mediato e tardio) e cuidados de enfermagem pós- transplante renal na atenção primária à saúde/extra-hospitalar. Conclusões: conclui-se que o estudo permitiu mapear os cuidados de enfermagem ao paciente transplantado renal nos pós-operatórios imediato, mediato, tardio e na atenção primária à saúde.


Subject(s)
Postoperative Period , Review Literature as Topic , Kidney Transplantation , Nursing Care , Nursing
3.
Rev. ecuat. pediatr ; 22(2): 1-7, 31 de agosto del 2021.
Article in Spanish | LILACS | ID: biblio-1284504

ABSTRACT

Introducción: El trasplante renal en pediatría constituye el tratamiento de elección para la enfermedad renal crónica terminal (ERCT) con ventajas ampliamente comprobadas sobre los tratamientos dialíticos. El objetivo del presente estudio fue determinar los factores de riesgo relacionados con la sobrevida global y del injerto en un grupo de pacientes pediátricos con trasplante renal atendidos en un hospital de referencia nacional con observación de factores asociados al hiperparatiroidismo secundario. Métodos: En el presente estudio observacional, retrospectivo, se realizó en el Hospital Metropolitano de Quito - Ecuador desde el primero de enero del 2010 al treinta de junio del 2013. Se registró la mortalidad y la supervivencia del injerto, presencia de hiperparatiroidismo pre trasplante, variables demográficas, clínicas (compatibilidad). Se usa el método de Kaplan Meier para el análisis y se presentan riesgos relativos. Resultados: Ingresaron al estudio 33 pacientes, de edad 12±3.8 años. Donante cadavérico 21 casos (63.6%), donante vivo 12 pacientes 36.4%. 18 hombres (54.5%). La etiología de la ERCT fue indeterminada en 63.6%; nefropatías en 24.2% y uropatías en 12.1%. Rechazo agudo 1 paciente, rechazo tardío 10 pacientes. Las variables con significancia en la sobrevida del injerto fueron: hiperparatiroidismo RR= 6.0 (IC95%= 1.078-45.902) P=0.032. No recibir inmunosupresión completa RR=14.5 (IC95%= 3.807-55.225) P<0.001. La necesidad de diálisis pos trasplante la primera semana y biopsia temprana tuvieron RR=15 (IC95%= 3.9-57.2). Conclusiones: Este estudio demostró que el hiperparatiroidismo secundario es un factor de riesgo negativo para la sobrevida del injerto renal en pacientes pediátricos trasplantados


Introduction: Kidney transplantation in pediatrics is the treatment of choice for end-stage renal disease (ESRD) with widely proven advantages over dialysis treatments. The aim of the present study was to determine the risk factors related to global and graft survival in a group of pediatric kidney transplant patients treated at a national referral hospital with observation of factors associated with secondary hyperparathyroidism. Methods: In the present observational, retrospective study, it was carried out in the Hospital Metropolitano de Quito - Ecuador from January 1, 2010 to June 30, 2013. Mortality and graft survival, presence of hyperparathyroidism pre transplantation, demographic and clinical variables (compatibility). The Kaplan Meier method is used for analysis and relative risks are presented. Results: 33 patients, aged 12 ± 3.8 years, entered the study. Cadaveric donor 21 cases (63.6%), living donor 12 patients 36.4%. 18 men (54.5%). The etiology of ESRD was indeterminate in 63.6%; nephropathies in 24.2% and uropathies in 12.1%. Acute rejection 1 patient, late rejection 10 patients. Variables with significance in graft survival were: hyperparathyroidism RR = 6.0 (95% CI = 1.078-45.902) P = 0.032. Not receiving complete immunosuppression RR = 14.5 (95% CI = 3.807-55.225) P <0.001. The need for post-transplant dialysis the first week and early biopsy had RR = 15 (95% CI = 3.9-57.2). Conclusions: This study demonstrated that secondary hyperparathyroidism is a negative risk factor for kidney graft survival in pediatric transplant patients.


Subject(s)
Humans , Child, Preschool , Child , Adolescent , Parathyroid Diseases , Prognosis , Kidney Transplantation , Child , Cause of Death , Critical Care
4.
Medisan ; 25(2)mar.-abr. 2021. ilus
Article in Spanish | LILACS, CUMED | ID: biblio-1250352

ABSTRACT

Se describe el caso clínico de un adolescente de 18 años con antecedente patológico de una operación por hipertelorismo en su primer año de vida, quien fue asistido en el Servicio de Nefrología del Hospital Infantil Docente Norte Dr. Juan de la Cruz Martínez Maceira de Santiago de Cuba, debido a una disminución marcada de la función renal, por lo cual requirió terapias sustitutivas. Su estado persistió por más de 3 meses y se consideró como una insuficiencia renal crónica en fase terminal. Se realizaron varios exámenes complementarios en busca de la causa y se interconsultó con otras especialidades, como la de Genética Clínica, por la presencia de trastornos dismórficos; finalmente, se diagnosticó el síndrome de Robinow. El paciente permaneció con hemodiálisis por 2 años hasta que su condición fue estable para recibir un trasplante de riñón.


The case report of an 18 years adolescent is described with pathological history of a surgery due to hypertelorism in his first year of life who was assisted in the Nephrology Service of Dr. Juan de la Cruz Martínez Maceira Northern Teaching Children Hospital in Santiago de Cuba, due to a marked decrease of the renal function, reason why he required substitute therapies. His condition persisted for more than 3 months and it was considered as a chronic kidney failure in end stage. Several complementary exams were carried out to find out the cause and other specialties participated in the diagnosis, as Clinical Genetics, due to the presence of dysmorphic disorders; finally, Robinow syndrome was diagnosed. The patient remained with hemodialysis for 2 years until her condition was stable to receive a renal transplant.


Subject(s)
Renal Insufficiency, Chronic , Genetics , Kidney Failure, Chronic , Renal Dialysis , Kidney Transplantation , Hypertelorism
5.
Int. j. med. surg. sci. (Print) ; 8(1): 1-13, mar. 2021. tab, graf
Article in Spanish | LILACS | ID: biblio-1151571

ABSTRACT

Las complicaciones cardiovasculares representan la principal causa de morbilidad y mortalidad en pacientes con enfermedad renal crónica, por lo que el objetivo de este artículo es demostrar la influencia de la permanencia de la fístula arteriovenosa sobre variables eco cardiográficamente mensuradas en el corazón izquierdo. Para ello, se definió un estudio multivariable, longitudinal, prospectivo y controlado de grupos independientes después de una intervención que incluyó 39 pacientes a los que se le cerró el angioacceso (grupo de estudio) y 42 que no fueron expuestos a la cirugía (grupo control). Ambos grupos exhibían trasplante renal funcionante. Los principales resultados surgenal comparar el predominio entre el grupo de estudio con el de control, la edad promedio; 45,6 y 44,1 años, el sexo masculino, 24 (60%) y 23 (53,5%) y el color de la piel blanca; 33 (82,5%) y 32 (74,4%). La etiología de la nefropatía originaria más frecuente fue la nefropatía vascular hipertensiva; 12 (30%) vs 14 (32,6%). Entre las manifestaciones clínicas, en el grupo de estudio se evidenció remisión de las palpitaciones y la disnea de esfuerzo. Respecto a la tensión arterial, para la sistólica oscilaba; de 123 ±13,4 a 120,5 ±9,2 vs de 125,6 ±8,4 a 128 ±8,3 mm Hg (p= 0,000), mientras la diastólica variaba de; 76,8 ±7,5 a 76,3 ±6,2 vs 78,6 ±4,9 a 82,4 ±3,9 mm Hg (p= 0,000). El hematocrito comportaba valores equivalentes; 0,43 ±0,06 y 0,45 ±0,06 vs 0,42 ±0,05 y 0,42 ±0,06 l/l (p= 0,035) y la creatinina sérica mostró descenso en los pacientes intervenidos de; 106,8 ± 26,2 hasta 99,8 ±23,9 µ Mol/l vs 114 ±27,8 a 120,3 ±31 µ Mol/l (p= 0,002). Las variables ecocardiográficas mensuradas comparativamente según la localización de los angioaccesos a nivel del codo izquierdo; diámetro del ventrículo izquierdo: 3,12 ±4,08 vs 1,48 ±3,46 mms (p=0,001), fracción de eyección del ventrículo izquierdo: 2,99 ±5,47 vs -1,98 ±6,23 % (p=0,018) y el volumen telediastólico: -23 ±33,41 vs 10,86 ±36,87 ml (p=0,006). El codo contralateral revelaba; para la fracción de eyección del ventrículo izquierdo: 3,32 ±3,42 vs -2,18 ±4,78 % (p=0,037) y para el gasto cardíaco: -1,29 ±0,88 vs -0,26 ±0,86 l/min (0,020). Las conclusiones demuestran que el cierre del angioacceso a pacientes con trasplante renal funcionante respecto a los no intervenidos, contribuye a la regresión de las alteraciones morfológicas y hemodinámicas constatadas por ecocardiografía transtorácica en el corazón izquierdo a nivel de las diferentes localizaciones de los accesos vasculares.


Cardiovascular complications represent the main cause of morbidity and mortality in patients with chronic renal disease, so the objective of this article is to demonstrate the influence of the patency of the arteriovenous fistula on echocardiographic variables measured in the left heart. For this, a multivariate study, longitudinal, prospective and controlled study of independent groups after an intervention that included 39 patients who had their angioaccess closed (study group) and 42 who were not exposed to surgery (control group). Both groups exhibited functional kidney transplantation. The main results emerge when comparing the prevalence between the study group and the control group, the average age; 45.6 and 44.1 years, the male sex, 24 (60%) and 23 (53.5%) and the white skin color; 33 (82.5%) and 32 (74.4%). The most frequent etiology of the original nephropathy was hypertensive vascular nephropathy; 12 (30%) vs 14 (32.6%). Among the clinical manifestations, remission of palpitations and dyspnea on exertion were evidenced in the study group. With regard to blood pressure, for the systolic it ranged from 123 ±13.4 to 120.5 ±9.2 vs. 125.6 ±8.4 to 128 ±8.3 mmHg (p= 0.000), while the diastolic varied from; 76.8 ±7.5 to 76.3 ±6.2 vs. 78.6 ±4.9 to 82.4 ±3.9 mmHg (p= 0.000). The hematocrit had equivalent values; 0.43 ±0.06 and 0.45 ±0.06 vs 0.42 ±0.05 and 0.42 ±0.06 l/l (p= 0.035) and the serum creatinine showed decrease in the operated patients from; 106.8 ±26.2 to 99.8 ±23.9 µMol/l vs 114 ±27.8 to 120.3 ±31 µMol/l (p= 0.002). The echocardiographic variables measured comparatively according to the location of the angioaccesses at the left elbow level; diameter of the left ventricle: 3.12 ±4.08 vs 1.48 ±3.46 mms (p=0.001), ejection fraction of the left ventricle: 2.99 ±5.47 vs -1.98 ±6.23 % (p=0.018) and the telediasolic volume: -23 ±33.41 vs 10.86 ±36.87 ml (p=0.006). The contralateral elbow revealed; for the left ventricular ejection fraction: 3.32 ±3.42 vs -2.18 ±4.78 % (p=0.037) and for cardiac output: -1.29 ±0.88 vs -0.26 ±0.86 l/min (0.020). The conclusions show that the our study has shown that closing the angioaccess to patients with functioning renal transplants with respect to those not operated, contributes to the regression of morphological and hemodynamic alterations observed by transthoracic echocardiography in the left heart at the different locations of the vascular accesses.


Subject(s)
Humans , Male , Female , Arteriovenous Fistula/physiopathology , Renal Dialysis , Renal Insufficiency, Chronic , Longitudinal Studies , Arteriovenous Fistula/surgery , Kidney Transplantation/adverse effects , Kidney Diseases/complications
7.
Diagn. tratamento ; 26(1): 12-15, jan.-mar. 2021.
Article in Portuguese | LILACS | ID: biblio-1247974

ABSTRACT

Contexto: A Listeria monocytogenes é um bacilo gram-positivo de baixa patogenicidade na população geral, mas importante causa de mortalidade por sepse e meningite em pacientes imunocomprometidos. Receptores de órgãos sólidos e candidatos em tratamento de dessensibilização são suscetíveis à infecção pela Listeria monocytogenes, embora sua apresentação clínica seja pouco reconhecida. Descrição dos casos: Paciente do sexo masculino, 43 anos, internado devido a rejeição aguda de enxerto pós-transplante renal, apresenta pico febril matutino e cefaleia. Paciente do sexo feminino, 59 anos, com doença renal crônica e em terapia de dessensibilização devido reatividade a painel antígeno leucocitário humano, busca pronto-socorro com febre, cefaleia e diarreia. A infecção por Listeria monocytogenes foi confirmada por hemocultura em ambos os casos. Discussão: A ocorrência de listeriose é esporádica e associada ao consumo de alimentos altamente contaminados, como laticínios, produtos frescos e carnes processadas. A redução da imunocompetência é o principal fator de risco para o desenvolvimento da doença em não gestantes, bem como para o aumento da mortalidade. O diagnóstico é estabelecido majoritariamente por hemocultura e o exame do líquido cefalorraquidiano é imprescindível para acessar o acometimento do sistema nervoso central, uma vez que os sinais meníngeos podem estar ausentes. O tratamento é realizado com beta-lactâmicos ou aminoglicosídeos. A ampicilina foi utilizada nos casos relatados e promoveu boa resposta clínica. Conclusão: Os profissionais devem atentar para a gravidade da infecção por Listeria monocytogenes e considerar sua ocorrência em pacientes imunocomprometidos, fornecendo orientações profiláticas a todos os candidatos a transplante de órgãos sólidos e tratamento empírico nos casos suspeitos.


Subject(s)
Humans , Male , Adult , Organ Transplantation , Desensitization, Immunologic , Kidney Transplantation , Listeriosis , Listeria monocytogenes
8.
Braz. j. med. biol. res ; 54(4): e9369, 2021. tab, graf
Article in English | LILACS | ID: biblio-1153534

ABSTRACT

Tacrolimus (TAC), a calcineurin inhibitor, and everolimus (EVL), an mTOR inhibitor, have been used as immunosuppressive (ISS) drugs in post-kidney transplantation therapy. The objective of this study was to compare the efficacy of EVL vs TAC in the ISS maintenance triple therapy. Ninety-seven kidney transplant patients, who received triple maintenance therapy with TAC, mycophenolate mofetil (MMF), and methyl prednisone (PRED), were evaluated. After four months of post-kidney transplant therapy, 30 patients enrolled in a randomized controlled clinical trial, in which 16 patients received TAC+MMF+PRED (cohort 1), and 14 patients switched to EVL+MMF+PRED (cohort 2). The patients were followed-up for 36 months. Two patients from cohort 1 lost their grafts after one year due to non-adherence. Two patients from cohort 2 had intolerance to mTOR inhibitors and were switched back to TAC from EVL. One case (6.25%) in cohort 1 and three cases (21.43%) in cohort 2 of acute T-cell-mediated rejection was observed. Antibody-mediated acute rejection (ABMAR) was observed in four patients (25.0%) in cohort 1, and antibody-mediated chronic rejection (ABMCR) was observed in two patients (12.50%). One patient from cohort 2 lost the graft after 15 months due to polyomavirus infection. The graft survival rate was 87.50% in cohort 1 and 92.86% in cohort 2. This clinical trial showed that the EVL+MMF+PRED triple maintenance therapy was efficacious compared with TAC during 32 months of follow-up. However, further studies are needed to confirm the efficacy of this regimen for long-term graft survival.


Subject(s)
Humans , Kidney Transplantation , Tacrolimus/therapeutic use , Drug Therapy, Combination , Everolimus/therapeutic use , Graft Rejection/prevention & control , Graft Survival , Immunosuppressive Agents/therapeutic use
9.
Braz. j. med. biol. res ; 54(6): e10558, 2021. tab
Article in English | LILACS | ID: biblio-1249309

ABSTRACT

Hypercalcemia is common in patients after kidney transplantation (KTx) and is associated with persistent hyperparathyroidism in the majority of cases. This retrospective, single-center study evaluated the prevalence of hypercalcemia after KTx. KTx recipients were evaluated for 7 years after receiving kidneys from living or deceased donors. A total of 301 patients were evaluated; 67 patients had hypercalcemia at some point during the follow-up period. The median follow-up time for all 67 patients was 62 months (44; 80). Overall, 45 cases of hypercalcemia were classified as related to persistent post-transplant hyperparathyroidism (group A), 16 were classified as "transient post-transplant hypercalcemia" (group B), and 3 had causes secondary to other diseases (1 related to tuberculosis, 1 related to histoplasmosis, and 1 related to lymphoma). The other 3 patients had hypercalcemia of unknown etiology, which is still under investigation. In group A, the onset of hypercalcemia after KTx was not significantly different from that of the other groups, but the median duration of hypercalcemia in group A was 25 months (12.5; 53), longer than in group B, where the median duration of hypercalcemia was only 12 months (10; 15) (P<0.002). The median parathyroid hormone blood levels around 12 months after KTx were 210 pg/mL (141; 352) in group A and 72.5 pg/mL (54; 95) in group B (P<0.0001). Hypercalcemia post-KTx is not infrequent and its prevalence in this center was 22.2%. Persistent hyperparathyroidism was the most frequent cause, but other important etiologies must not be forgotten, especially granulomatous diseases and malignancies.


Subject(s)
Humans , Kidney Transplantation/adverse effects , Hypercalcemia/etiology , Hypercalcemia/epidemiology , Hyperparathyroidism , Parathyroid Hormone , Calcium , Retrospective Studies , Kidney
10.
Rev. méd. Urug ; 37(2): e901, 2021. tab
Article in Spanish | LILACS, BNUY | ID: biblio-1280508

ABSTRACT

Resumen: Este documento de recomendaciones tiene como objetivo orientar a médicos nefrólogos y no nefrólogos que asisten a pacientes con enfermedad renal crónica (ERC) en todas las etapas de la misma, en el proceso de vacunación contra el SARS-CoV-2. Como consecuencia de la situación epidemiológica y de los tiempos del proceso de elaboración de las vacunas disponibles, no se ha generado evidencia lo suficientemente potente, por lo que las recomendaciones no se acompañan del nivel de evidencia. Se fundamenta la necesidad de priorizar la vacunación en este grupo de pacientes en el mayor riesgo de adquirir la infección por SARS-CoV-2, desarrollar la enfermedad COVID-19 con mayor gravedad y presentar una mortalidad más elevada que la población general. Las recomendaciones se organizan por grupos de pacientes considerando pacientes con ERC no dialítica, diálisis y trasplante renal, y pacientes bajo tratamiento inmunosupresor.


Summary The objective of this document containing recommendations is to provide guidelines for nephrologists and non-nephrologists who assist patients with chronic kidney disease (CKD) at all stages of the disease on the vaccination process against SARS-CoV-2. As a consequence of the current epidemiological situation and the timing of the COVID-19 vaccine development -for available vaccines- there is no solid evidence, and thus, recommendations are not accompanied by the due medical proof. The need to prioritize vaccination in this group of patients is based on the increased risk of acquiring the SARS-CoV-2 infection, developing the COVID-19 disease with greater severity and presenting higher mortality rates than the general population. The recommendations are organized by groups of patients, considering patients with non-dialytic CKD, dialysis and kidney transplantation, and patients under immunosuppressive treatment.


Resumo: O objetivo deste documento de recomendações é orientar os nefrologistas e não nefrologistas que atendem pacientes com doença renal crônica (DRC) em todas as fases da doença, no processo de vacinação contra a SARS-CoV-2. Como consequência da situação epidemiológica e do momento do processo de produção das vacinas disponíveis, não foram geradas evidências suficientemente potentes, de modo que as recomendações não são acompanhadas de seu nível de evidência. A necessidade de priorizar a vacinação neste grupo de pacientes baseia-se no maior risco de adquirir a infecção pelo SARS-CoV-2, desenvolver a doença COVID-19 com maior gravidade e apresentar mortalidade superior à da população em geral. As recomendações são organizadas por grupos de pacientes, considerando pacientes com DRC não dialítica, em diálise, com transplante renal, e pacientes em tratamento imunossupressor.


Subject(s)
Renal Dialysis , Kidney Transplantation , Renal Insufficiency, Chronic , COVID-19 Vaccines
11.
Rev. saúde pública (Online) ; 55: 33, 2021. tab, graf
Article in English | LILACS, BBO | ID: biblio-1252116

ABSTRACT

ABSTRACT OBJECTIVE To estimate the prevalence and variability of nonadherence to immunosuppressives and nonpharmacological treatment across kidney transplantation centers and two health access-disparate regions in Brazil. METHODS In a cross-sectional design, a random multistage sample of 1,105 patients was included, based on center transplantation activity (low/moderate/high) and region (R1: North/Northeast/Mid-West; and R2: South/Southeast). Nonadherence to immunosuppressives (implementation phase) was assessed using the Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS)©. Self-report questionnaires assessed nonadherence to physical activity, smoking cessation, alcohol intake, and appointment keeping. We compared regions using the adjusted-χ2 or t-test. RESULTS Most patients were men (58.5%), white (51.4%), and had a mean age of 47.5 (SD = 12.6) years. Regarding kidney transplantation centers, 75.9% were from R2 and 38.2% had low activity. The patients in R2 were older, white-majority, had more frequently steady partners, and received peritoneal dialysis. Nonadherence to immunosuppressives ranged from 11-65.2%; 44.5-90% to physical activity; 0-23.7% to appointment keeping; and 0-14% to smoking cessation. The total prevalence of nonadherence and by region (R1 versus R2) were: for immunosuppressives, 39.7% (44.9% versus 38.1%, p = 0.18); for smoking, 3.9% (1% versus 5%, p < 0.001); for physical activity, 69.1% (71% versus 69%, p = 0.48); for appointment keeping, 13% (12.7% versus 12%, p = 0.77); and for alcohol consumption, 0%. CONCLUSION Despite differences among centers and high variability, only the nonadherence to smoking cessation was higher in the region with greater access to kidney transplantation. We suppose that differences in healthcare access may have been overcome by other positive aspects of the post kidney transplantation treatment.


Subject(s)
Humans , Male , Female , Kidney Transplantation , Brazil , Cross-Sectional Studies , Medication Adherence , Immunosuppressive Agents/therapeutic use , Middle Aged
12.
Clinics ; 76: e2597, 2021. tab, graf
Article in English | LILACS | ID: biblio-1153997

ABSTRACT

A combination of immunosuppressants may improve outcomes due to the synergistic effect of their different action mechanisms. Currently, there is no consensus regarding the best immunosuppressive protocol after liver transplantation. This review aimed to evaluate the effectiveness and safety of tacrolimus associated with mycophenolate mofetil (MMF) in patients undergoing liver transplantation. We performed a systematic review and meta-analysis of randomized clinical trials. Eight randomized trials were included. The proportion of patients with at least one adverse event related to the immunosuppression scheme with tacrolimus associated with MMF was 39.9%. The tacrolimus with MMF immunosuppression regimen was superior in preventing acute cellular rejection compared with that of tacrolimus alone (risk difference [RD]=-0.11; p =0.001). The tacrolimus plus MMF regimen showed no difference in the risk of adverse events compared to that of tacrolimus alone (RD=0.7; p=0.66) and cyclosporine plus MMF (RD=-0.7; p=0.37). Patients undergoing liver transplantation who received tacrolimus plus MMF had similar adverse events when compared to patients receiving other evaluated immunosuppressive regimens and had a lower risk of acute rejection than those receiving in the monodrug tacrolimus regimen.


Subject(s)
Humans , Kidney Transplantation , Liver Transplantation , Randomized Controlled Trials as Topic , Immunosuppression , Tacrolimus/adverse effects , Drug Therapy, Combination , Graft Rejection/prevention & control , Immunosuppressive Agents/adverse effects , Mycophenolic Acid/adverse effects
13.
Einstein (Säo Paulo) ; 19: eAO6069, 2021. tab, graf
Article in English | LILACS | ID: biblio-1286308

ABSTRACT

ABSTRACT Objective To evaluate the ability of blood-oxygen-level-dependent (BOLD) magnetic resonance imaging at 3 Tesla to measure tissue oxygen bioavailability based on R2* values, and to differentiate between acute tubular necrosis and acute rejection compared to renal biopsy (gold standard). Methods A prospective, single-center study, with patients submitted to renal transplantation between 2013 and 2014, who developed graft dysfunction less than 4 weeks after transplantation. All patients were submitted to abdominal magnetic resonance imaging at 3 Tesla using the same protocol, followed by two BOLD sequences and kidney biopsy. Results Twelve male (68.75%) and three female (31.25%) patients were included. A total of 19 percutaneous renal biopsies were performed (four patients required a second biopsy due to changes in clinical findings). Pathological findings revealed ten cases of acute tubular necrosis, four cases of acute rejection, and five cases with other (miscellaneous) diagnoses. Comparison between the four groups of interest failed to reveal significant differences (p=0.177) in cortical R2* values, whereas medullary R2* values differed significantly (p=0.033), with lower values in the miscellaneous diagnoses and the acute tubular necrosis group. Conclusion BOLD magnetic resonance imaging at 3 Tesla is a feasible technique that uses indirect tissue oxygen level measurements to differentiate between acute rejection and acute tubular necrosis in renal grafts.


RESUMO Objetivo Avaliar a sequência de ressonância magnética blood-oxygen-level-dependent (BOLD) realizada em um equipamento 3 Tesla para medir a biodisponibilidade do oxigênio do tecido pelo valor de R2* na diferenciação de necrose tubular aguda e rejeição aguda, comparando à biópsia renal (padrão-ouro). Métodos Estudo unicêntrico, prospectivo, com pacientes submetidos a transplante renal de 2013 a 2014, que desenvolveram disfunção do enxerto menos de 4 semanas após o transplante. Todos os pacientes foram submetidos à ressonância magnética abdominal 3 Tesla com o mesmo protocolo, seguida de duas sequências BOLD e biópsia renal. Resultados Foram incluídos 12 homens (68,75%) e três mulheres (31,25%). Foram realizadas 19 biópsias renais percutâneas (quatro pacientes necessitaram de segunda biópsia devido à alteração nos achados clínicos). Os resultados histopatológicos incluíram dez casos de necrose tubular aguda, quatro de rejeição aguda e cinco casos de outros diagnósticos (miscelânea). A comparação entre os quatro grupos de interesse não mostrou diferenças significativas em relação ao R2* no córtex (p=0,177). Quanto ao R2* da medula, observaram-se diferenças significativas (p=0,033), com miscelânea e necrose tubular aguda apresentando valores mais baixos quando comparados aos demais. Conclusão A ressonância magnética BOLD 3 Tesla é uma técnica viável que indiretamente utiliza a concentração de oxigênio no tecido em enxertos renais e pode ser usada para a diferenciação entre rejeição aguda e necrose tubular aguda.


Subject(s)
Humans , Male , Female , Kidney Transplantation , Oxygen , Biopsy , Prospective Studies , Allografts
14.
Med. lab ; 25(2): 525-534, 2021. ilus, graf
Article in Spanish | LILACS | ID: biblio-1342894

ABSTRACT

El cáncer es una causa importante de morbilidad y mortalidad en los receptores de trasplante. La combinación de infecciones virales, terapia de inmunosupresión y la alteración en el sistema inmune en los pacientes trasplantados, contribuyen al desarrollo de cáncer. El sarcoma de Kaposi es causado por el virus herpes humano 8 (VHH-8), y aunque es raro en la población general, puede ser hasta 300 veces más frecuente en los pacientes con trasplante renal. El diagnóstico de la enfermedad se realiza a menudo con base en las características de las lesiones, pero debe ser confirmado por histología. En años recientes, los inhibidores de mTOR han mostrado ser efectivos para el control del sarcoma de Kaposi en los pacientes trasplantados, ya que se interrumpe el efecto antiapoptótico y la angiogénesis dependientes de la proteína mTOR, los cuales son esenciales para el desarrollo y la propagación de células malignas. Se presentan dos casos de pacientes con sarcoma de Kaposi ganglionar, sin lesiones en piel, en nuestro centro de trasplante, quienes respondieron de manera positiva al cambio del esquema inmunosupresor con inhibidores de mTOR


Cancer is a major cause of morbidity and mortality in transplant recipients. The combination of viral infections, immunosuppression therapy and immune system dysfunction in transplant patients contribute to the development of cancer. Kaposi sarcoma is caused by human herpes virus 8 (HHV-8) and although rare in the general population, it is reported to be up to 300 times more common in kidney transplant patients. Diagnosis of the disease is often made on the basis of the characteristic appearance of lesions, but must be confirmed by histology. In recent years, mTOR inhibitors have been shown to be effective in controlling Kaposi sarcoma in transplant patients, due to disruption of the antiapoptotic effect and angiogenesis dependent on the mTOR protein, which are essential for development and propagation of malignant cells. We present two case reports of patients with Kaposi sarcoma in lymph nodes and no skin lesions, who responded well to the immunosuppressive therapy switch with mTOR inhibitors


Subject(s)
Humans , Sarcoma, Kaposi , Kidney Transplantation , Herpesvirus 8, Human , TOR Serine-Threonine Kinases , Lymph Nodes
15.
Rev. Pesqui. (Univ. Fed. Estado Rio J., Online) ; 13: 1388-1394, jan.-dez. 2021. ilus
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1292015

ABSTRACT

Objective:To analyze how the literature presents the quality of life in renal transplant patients. Methods: base review study: MEDLINE, LILACS and SCIELO. The descriptors kidney Transplantation and quality of life were used, combined with the boolean operator and. After considering the criteria, 15 articles were fully analyzed.Results: the publications showed that the transplantation contributes to the improvement of the patient's quality of life, although, compared to the general population, this quality is lower. Factors such as: presence of comorbidities, transplantation time, educational level and psychological aspects influence the patient's view of their quality of life.Conclusion: the quality of life after transplantation is surrounded by multiple aspects and particularities. Finding the benefits of transplantation for the renal patient does not exempt the possibility of negative dimensions that may compromise the perception of quality of life


Objetivo: Analisar como a literatura apresenta a qualidade de vida em paciente transplantado renal. Métodos: estudo de revisão nas bases: MEDLINE, LILACS e SCIELO. Utilizou-se os descritores "Kidney Transplantation" e "Quality of Life", combinando-se com o operador booleano AND. Após consideração dos critérios, foram analisados integralmente 15 artigos. Resultados: As publicações evidenciaram que o transplante contribui para melhoria da qualidade de vida do paciente, ainda assim, se comparado à população geral essa qualidade é inferior. Fatores como: presença de comorbidades, tempo de transplante, nível de escolaridade e aspectos psicológicos influenciam a visão que o paciente possui da sua qualidade de vida. Conclusão: a qualidade de vida após o transplante é envolta de múltiplos aspectos e particularidades. A constatação dos benefícios do transplante para o doente renal, não isenta a possibilidade da existência de dimensões negativas as quais podem comprometer a percepção da qualidade de vida.


Objetivo: Analizar cómo la literatura presenta la calidad de vida en pacientes con trasplante renal.Métodos: estudio de revisión base: MEDLINE, LILACS y SCIELO. Se utilizaron los descriptores trasplante de riñón y calidad de vida, combinados con el operador booleano and. Después de considerar los criterios, 15 artículos fueron completamente analizados. Resultados: las publicaciones mostraron que el trasplante contribuye a la mejora de la calidad de vida del paciente, aunque, en comparación con la población general, esta calidad es menor. Factores como: presencia de comorbilidades, tiempo de trasplante, nivel educativo y aspectos psicológicos influyen en la visión del paciente sobre su calidad de vida.Conclusión: la calidad de vida después del trasplante está rodeada de múltiples aspectos y particularidades. Encontrar los beneficios del trasplante para el paciente renal no exime la posibilidad de dimensiones negativas que pueden comprometer la percepción de la calidad de vida


Subject(s)
Humans , Male , Female , Quality of Life , Kidney Transplantation , Kidney Diseases/surgery
16.
Rev. Soc. Bras. Med. Trop ; 54: e0269-2020, 2021. graf
Article in English | LILACS | ID: biblio-1155566

ABSTRACT

Abstract Reactivation of chronic Trypanosoma cruzi infection in solid organ transplant recipients (SOTRs) has been reported. The patient presented with a 2-week history of two painful erythematous, infiltrated plaques with central ulceration and necrotic crust on the left thigh. She had a history of chronic indeterminate Chagas disease (CD) and had received a kidney transplant before 2 months. Skin biopsies revealed lobular panniculitis with intracellular amastigote forms of T. cruzi. The patient was diagnosed with CD reactivation. Treatment with benznidazole significantly improved her condition. CD reactivation should be suspected in SOTRs living in endemic areas with clinical polymorphism of skin lesions.


Subject(s)
Humans , Female , Trypanosoma cruzi , Panniculitis , Kidney Transplantation/adverse effects , Chagas Disease/diagnosis , Thigh
18.
Cad. Saúde Pública (Online) ; 37(6): e00043620, 2021. tab, graf
Article in Portuguese | LILACS | ID: biblio-1249465

ABSTRACT

Resumo: Este estudo avaliou a prevalência e os fatores associados a não procura por transplante renal entre pacientes em diálise crônica na Região Metropolitana de Fortaleza, Ceará, Brasil. Foram excluídos os pacientes sem condições clínicas e aqueles em avaliação pré-transplante renal. Um questionário semiestruturado foi aplicado, incluindo opções para a pergunta "Qual o principal motivo pelo qual o senhor/senhora não está inscrito(a) para o transplante renal?". A prevalência de pacientes considerados aptos, mas não inscritos e nem em avaliação pré-transplante renal foi de 50,7%. As principais causas foram: receio de insucesso/perda do enxerto (32,5%), dificuldade de transporte e acesso aos exames (20,9%) e problemas pessoais ou familiares temporários (13,7%). Em análise múltipla, as variáveis associadas a risco de receio do insucesso/perda do enxerto foram: sexo feminino (OR = 1,763; IC95%: 1,224-2,540) e doença renal dialítica (DRC 5-D) por hipertensão (OR = 1,732; IC95%: 1,178-2,547), tendo a renda mensal (salários mínimos) uma associação de proteção (OR = 0,882; IC95%: 0,785-0,991). O tempo em diálise (meses) foi um fator de risco para a dificuldade de transporte e acesso aos exames (OR = 1,004; IC95%: 1,001-1,007) e o sexo feminino apresentou uma associação de proteção (OR = 0,576; IC95%: 0,368-0,901). Esses resultados mostram elevada prevalência de pacientes em diálise fora de lista para transplante renal. As principais causas são reflexo da desinformação e falta de acesso. Sexo feminino, baixa renda e DRC 5-D por hipertensão foram os fatores de risco para a não procura por transplante renal por receio de perda do enxerto, reflexo da carência de informações sobre a modalidade. Sexo masculino e maior tempo em diálise foram os fatores de risco para a dificuldade de acesso à terapia.


Abstract: This study evaluated the prevalence and factors associated with lack of enrollment for kidney transplant among patients in chronic dialysis in Greater Metropolitan Fortaleza, Ceará, Brazil. The sample excluded patients with insufficient clinical status and those already in pre-kidney transplant evaluation. A semi-structured questionnaire was applied, including options for the question, "What is the main reason why you are not enrolled for kidney transplant?" Prevalence of patients considered fit but not enrolled or in pre- kidney transplant evaluation was 50.7%. The main reasons were fear of failure/loss of grafting (32.5%), difficulty with transportation or access to tests (20.9%), and temporary personal or family problems (13.7%). In the multivariate analysis, the variables associated with fear of failure or loss of graft were female sex (OR = 1.763; 95%CI: 1.224-2.540) and end-stage renal disease (ESRD) due to hypertension (OR = 1.732; 95%CI: 1.178-2.547), while monthly income (number of minimum wages) showed a protective association (OR = 0.882; 95%CI: 0.785-0.991). Time on dialysis (months) was a risk factor for difficulty with transportation and access to tests (OR = 1.004; 95%CI: 1.001-1.007), and female sex showed a protective association (OR = 0.576; 95%CI: 0.368-0.901). These results show high prevalence of patients in dialysis not enrolled on the kidney transplant waitlist. The main causes were lack of information and lack of access. Female sex, low income, and ESRD due to hypertension were risk factors for lack of enrollment on the kidney transplant waitlist due to fear of loss of graft, resulting from lack of information on this treatment modality. Male sex and longer time on dialysis were risk factors for difficulty in access to kidney transplant.


Resumen: Este estudio evalúo la prevalencia y los factores asociados a la no búsqueda de un trasplante renal entre pacientes con diálisis crónica en la Región Metropolitana de Fortaleza, Ceará, Brasil. Se excluyeron a pacientes sin condiciones clínicas y aquellos en evaluación pre-trasplante renal . Se aplicó un cuestionario semiestructurado, incluyendo opciones a la pregunta "¿cuál es el principal motivo por el cual usted no está inscrito(a) para un trasplante renal?" La prevalencia de pacientes considerados aptos, pero no inscritos y ni en evaluación pre-trasplante renal fue de un 50,7%. Las principales causas fueron: recelo al fracaso/pérdida del injerto (32,5%), dificultad de transporte y acceso a los exámenes (20,9%), así como problemas personales o familiares temporales (13,7%). En el análisis múltiple, las variables asociadas al riesgo del recelo al fracaso/pérdida del injerto fueron de sexo femenino (OR = 1,763; IC95%: 1,224-2,540) y enfermedad renal dialítica (DRC 5-D) por hipertensión (OR = 1,732; IC95%: 1,178-2,547), teniendo la renta mensual (salarios mínimos) una asociación de protección (OR = 0,882; IC95%: 0,785-0,991). El tiempo en diálisis (meses) fue un factor de riesgo para la dificultad en el transporte y acceso a los exámenes (OR = 1,004; IC95%: 1,001-1,007), y el sexo femenino tuvo una asociación de protección (OR = 0,576; IC95%: 0,368-0,901). Estos resultados muestran la elevada prevalencia de pacientes en diálisis fuera de la lista para transplante renal. Las principales causas son reflejo de la desinformación y falta de acceso. Sexo femenino, baja renta y DRC 5-D por hipertensión fueron factores de riesgo para la no búsqueda de trasplante renal por recelo a la pérdida del injerto, reflejo de la carencia de información sobre la modalidad. Sexo masculino y mayor tiempo en diálisis fueron factores de riesgo para la dificultad de acceso a la terapia. izará la atención a las vulnerabilidades individuales desde la perspectiva de la salud integral.


Subject(s)
Humans , Male , Female , Prevalence , Kidney Transplantation/adverse effects , Kidney Failure, Chronic/surgery , Kidney Failure, Chronic/epidemiology , Brazil/epidemiology , Risk Factors , Renal Dialysis
19.
Medicina (B.Aires) ; 80(6): 611-621, dic. 2020. graf
Article in English | LILACS | ID: biblio-1250283

ABSTRACT

Abstract Infections are frequent complications of kidney transplants. We aimed at determining the frequency and type of infections that occur in renal transplant recipients during the early (0-1 month), intermediate (1-6 months) and late (6-12 months) post-transplant period and analyzing the risk factors for infection. To this aim, we conducted a retrospective cohort study on 1-year post-transplant follow-up in two third-level university hospitals in Cordoba city. All consecutive recipients of renal transplants performed between 2009 and 2015 were included, except those with multiple solid organ transplantation and pediatric patients. We included 375 recipients, of which 235 (62.7%) had at least one episode of infection during follow-up. There were 504 episodes of infection, of which 131 (26%) occurred in the early, 272 (53.9%) in the intermediate, and 101 (20.1%) in the late post-transplant period. The most frequent infections in all periods were caused by bacteria (mainly urinary tract infections), and the most frequent viral infection was caused by Cytomegalovirus (mainly in the second and third period). In the multivariate analysis, infection risk factors were: age > 60 years (adjusted odds ratio [aOR] = 1.92; 95% CI = 1.05-3.49), organ transplantation from deceased donor (aOR = 8.19; 95% CI = 2.32-28.9), use of pigtail catheter for urinary tract drainage (aOR = 4.06; 95% CI = 1.27-12.9), and number of days in hospital after transplant (aOR = 1.05; 95% CI = 1.01-1.11). In conclusion, infections in renal transplant recipients represent a very frequent health problem in our hospitals. Understanding the local epidemiology of infection and the potential risk factors for infection acquires utmost importance.


Resumen Las infecciones son complicaciones frecuentes de los trasplantes renales. Los objetivos del estudio fueron determinar la frecuencia y el tipo de infecciones que ocurren en el período post-trasplante temprano (0-1 mes), intermedio (1-6 meses) y tardío (6-12 meses) en nuestro medio y analizar los factores de riesgo de infección. Se realizó un estudio de cohorte retrospectivo que incluyó todos los pacientes con trasplantes renales realizados entre 2009 y 2015 en dos hospitales universitarios de tercer nivel de la ciudad de Córdoba, excluidos los receptores de trasplante simultáneo de múltiples órganos sólidos y los menores de 18 años. Fueron incluidos 375 pacientes, de los cuales 235 (62.7%) tuvieron al menos un episodio de infección. Hubo 504 episodios de infección: 131 (26%) ocurrieron en el período temprano, 272 (53.9%) en el intermedio y 101 (20.1%) en el tardío. La mayoría de las infecciones fueron de origen bacteriano (principalmente del tracto urinario). La mayoría de las infecciones virales ocurrieron en el segundo y el tercer período y Citomegalovirus fue el responsable más frecuente. En el análisis multivariado, los factores de riesgo de infección post-transplante renal fueron: edad > 60 años (odds ratio ajustado [aOR] 1.92; IC95% 1.05-3.49), donante cadavérico (aOR 8.19; IC95% 2.32-28.9), uso de catéter pigtail (aOR 4.06; IC95% 1.27-12.9) y número de días internado postrasplante (aOR 1.05; IC95% 1.01-1.11). En conclusión, confirmamos que las infecciones en pacientes con trasplante renal son muy frecuentes en nuestro medio, por lo cual es importante conocer la epidemiología local y los factores de riesgo.


Subject(s)
Humans , Child , Urinary Tract Infections , Kidney Transplantation/adverse effects , Tissue Donors , Retrospective Studies , Risk Factors
20.
Rev. colomb. nefrol. (En línea) ; 7(supl.2): 70-88, jul.-dic. 2020. graf
Article in Spanish | LILACS, COLNAL | ID: biblio-1251580

ABSTRACT

Resumen Introducción: los pacientes con trasplante renal y COVID-19 tienen alto riesgo de complicaciones y mortalidad dado que con mayor frecuencia presentan compromiso respiratorio. Hasta el momento, en Colombia no existen protocolos establecidos sobre el manejo de la inmunosupresión de base ni sobre estrategias de tratamiento en esta población, por lo que es necesario establecer recomendaciones basadas en la evidencia disponible y en el consenso de expertos para que sean aplicadas a nivel local. Objetivo: desarrollar mediante un consenso de expertos y una revisión de la literatura una serie de recomendaciones para diagnosticar y prevenir el contagio de SARS-CoV-2 en pacientes con trasplante renal, así como para darles un manejo adecuado. Materiales y métodos: se formularon una serie de preguntas sobre infección por SARS-CoV-2 en trasplante renal con énfasis en comportamiento clínico, frecuencia de la infección, prevención, diagnóstico, manejo de la inmunosupresión y tratamiento, a partir de las cuales se realizó una búsqueda de la literatura en las bases de datos PubMed y EMBASE y en los portales web de algunas sociedades científicas y se consultó a un grupo de especialistas en nefrología y cirugía. La discusión de las preguntas, las respuestas y lo encontrado en la literatura se realizó entre el 23 de abril y el 10 de mayo de 2020. Resultados: se realizó un panel de discusión donde los expertos discutieron y evaluaron la calidad de la evidencia para emitir una recomendación final sobre cada punto evaluado. Asimismo, se realizó un consolidado de las principales series de casos de infección por SARS-CoV2 en población con trasplante renal y sus desenlaces clínicos publicados hasta el momento. Conclusiones: se establecieron unas recomendaciones para la prevención, el diagnóstico y el manejo de pacientes con trasplante renal y COVID-19, las cuales hacen énfasis en el manejo inmunosupresor de base y resaltan la importancia de las interacciones farmacológicas de los tratamientos disponibles para el SARS-CoV-2 con la terapia inmunosupresora. Igualmente se dan recomendaciones para realizar trasplantes de forma segura durante la pandemia.


Abstract Introduction: Kidney transplant patients are a high-risk population for complications and mortality associated with SARS CoV2 infection. Different reports in the literature have shown a higher frequency of respiratory compromise and mortality, currently don't exist recommendations with an adequate level of evidence regarding the management of base immunosuppression and treatment strategies in this population, for which reason it is necessary from the national scene, build recommendations based on the available evidence and consensus of experts, to be applied at the local level. Objective: To develop, by means of an expert consensus and a review of the available literature, recommendations for the prevention, diagnosis and management of transplant patients with SARS Cov2 infection. And give recommendations to continue with the organ procurement and transplant activity in the scenario of the COVID-19 pandemic. Materials and methods: Questions were asked about SARS Cov2 infection in kidney transplantation, with emphasis on clinical behavior, frequency of infection, prevention, diagnosis, management of immunosuppression and treatment. A search of the literature in Pubmed, Embase and scientific societies was performed to answer each of the questions. The discussion of the answers to each of the questions according to the available evidence and the possibility of adapting them to local practice was carried out by consensus method and panel of experts. Nephrology and transplant surgery specialists from transplant groups in the country participated in the consensus. Results: A panel of experts was held to discuss the questions and answers found in the literature between April 23, 2020 and May 10, 2020, for each question a panel discussion was held where the total of experts discussed and Evaluates the quality of the evidence to issue a final recommendation on each evaluated point. A consolidation of the main series of cases of SARS-CoV2 infection in the kidney transplant population and the clinical outcomes was carried out up to the moment of publication. Conclusions: According to what is found in the literature, recommendations are made for the prevention, diagnosis and management of patients with kidney transplantation and SARS-CoV2 infection, emphasizing behavior with respect to basic immunosuppressive management, and highlighting the importance of the pharmacological interactions of the available treatments for SARS-CoV2 with immunosuppressive therapy, recommendations are also given to implement the procupara and transplant activity safely during the pandemic.


Subject(s)
Humans , Male , Female , Kidney Transplantation , COVID-19 , Patients , Colombia , Pandemics , Betacoronavirus , Nephrology
SELECTION OF CITATIONS
SEARCH DETAIL